Effect of vehicle on diclofenac sodium permeation from new topical formulations: In vitro and in vivo studies

Current Drug Delivery

Volumn 6, Issue 1, 2009, Pages 93-100

  Sanna, Vanna ^a   Peana, Alessandra T ^b   Moretti, Mario D L ^b  

^a Porto Conte Ricerche Srl   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Diclofenac sodium; In vitro diffusion; In vivo studies

Indexed keywords

CARBOMER; CARRAGEENAN; DICLOFENAC; DICLOFENAC DIETHYLAMINE; DODECYL SULFATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; HYDROPHILICITY; HYDROPHOBICITY; HYPERALGESIA; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SKIN PENETRATION; VISCOSITY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; MALE; RATS; RATS, WISTAR; SOLUBILITY; VEHICLES; VISCOSITY;

EID: 61849153563     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109787048311     Document Type: Article

References (38)

1. Skoutakis, V.A.; Carter, C.A.; Mickle, T.R.; Smith, V.H.; Arkin, C.R.; Alissandratos, J.; Petty, D.E. Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflammatory agent. Drug Intell. Clin. Pharm., 1988, 22, 850-59.
2. Mitchell, J.A.; Warner, T.D. Cyclooxigenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br. J. Pharmacol., 1999, 128, 1121-32.
3. Todd, P.A.; Sorkin, E.M. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs, 1988, 35, 244-85.
4. Nokhodchi, A.; Nazemiyeh, H.; Ghafourian, T.; Hassan-Zadeh, D.; Valizadeh, H.; Bahary, L.A.S. The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations. Il Farmaco, 2002, 57, 883-88.
5. Heyneman, C.A.; Lawless-Liday, C.; Wall, G.C. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs, 2000, 60, 555-74.
6. Boinpally, R.R.; Zhou, S.L.; Poondru, S.; Devraj, G.; Jasti, B.R. Lecithin vesicles for topical delivery of diclofenac. Eur. J. Pharm. Biopharm., 2003, 56, 389-92.
7. Vaile, J.H.; Davis, P. Topical NSAIDs for musculoskeletal conditons. A review of the literature. Drugs, 1998, 56, 783-99.
8. Sawynok, J. Topical and Peripherally Acting Analgesics. J. Pharmacol. Rev., 2003, 55, 1-20.
9. Jones, M.J. Chronic neuropathic pain: pharmacological interventions. The new millennium. A theory of efficacy. Int. J. Pharm. Compd., 2000, 4, 6-15.
10. Padilla, M.; Clark, G.T.; Merrill, R.L. Topical medication for orofacial neuropathic pain: a review. J. Am. Dent. Assoc., 2000, 131, 184-95.
11. Nishihata, T.; Kotera, K.; Nakano, Y.; Yamazaki, M. Rat percutaneous transport of diclofenac and influence of hydrogenated soya lecithin. Chem. Pharm. Bull., 1987, 35, 3807-12.
12. Takahashi, K.; Tamagawa, S.; Katagi, T.; Yoshitomi, H.; Kamada, A.; Rytting, J.; Nishihata, T.; Mizuno, N. In vitro percutaneous transport of sodium diclofenac and diclofenac from oleaginous vehicle. Chem. Pharm. Bull., 1991, 39, 509-11.
13. Obata, Y.; Takayama, M.; Maitani, Y.; Machida, Y.; Nagai, T. Effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int. J. Pharm., 1993, 89, 191-98.
14. Özgüney, I.S.; Karasulu, H.Y.; Kantarci, G.; Sözer, S.; Güneri,T.; Ertan, G. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS J., 2006, 7 (4), Article 88.
15. Arellano, A.; Santoyo, S.; Martin, C.; Ygartua, P. Enhancing effect of terpens on the in vitro percutaneous absorption of diclofenac sodium. Int. J. Pharm., 1996, 130, 141-45.
16. Escribano, E.; Calpena, A.C.; Queralt, J.; Obach. R.; Domenech, J. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur. J. Pharm. Sci., 2003, 19, 203-10.
17. Sherertz, E.F.; Sloan, K.B.; McTiernan, R.G. Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil. J. Invest. Dermatol., 1987, 89, 147-51.
18. Nesseem, D.I. Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. J. Pharm. Biomed. Anal., 2001, 26, 387-99.
19. Parsaee, S.; Sarbolouki, M.N.; Parnianpour, M. In-vitro release of diclofenac diethylammonium from lipid-based formulations. Int. J. Pharm., 2002, 241, 185-90.
20. Bonina, F.P.; Carelli, V.; Di Colo, G.; Montenegro, L.; Nannipieri, E. Vehicles effects on in vitro skin permeation of and stratum corneum affinity for model drugs caffeine and testosterone. Int. J. Pharm., 1993, 100, 41-7.
21. Maitani, Y.; Coutel-Egros, A.; Obata, Y.; Nagai, T. Prediction of skin permeabilities of diclofenac and propranolol from theoretical partition coefficients determined from cohesion parameters. J. Pharm. Sci., 1993, 82, 416-20.
22. Winter, C.A.; Risley, E.A.; Nuss, G.W. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med., 1962, 111, 544-47.
23. Dirig, D.M.; Isakson, P.C.; Yaksh, T.L. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J. Pharmacol. Exp. Ther., 1998, 285, 1031-38.
24. Hargreaves, K.; Dubner, R.; Brown, F.; Flores, C.; Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 1988, 32, 77-88.
25. Lucero, M.J.; Vigo, J.; Leon, M.J. A study of shear and compression deformations on hydrophilic gels of tretinoin. Int. J. Pharm., 1994, 106, 125-33.
26. Wang, Y.Y.; Hong, C.T.; Chiu, W.T.; Fang, J.Y. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int. J. Pharm., 2001, 224, 89-104.
27. Pose-Vilarnovo, B.; Rodriguez-Tenreiro, C.; dos Santos, J. F. R.; Vazquez-Doval, J.; Concheiro, A.; Alvarez-Lorenzo, C.; Torres-Labandeira, J. J. Modulating the drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J. Control. Release, 2004, 94, 351-63.
28. Zhou, M.; Donovan, M.D. Intranasal mucociliary clearance of putative bioadhesive polymer gels. Int. J. Pharm., 1996, 135, 115-25.
29. Shin, S.C.; Kim, H.J.; Oh, I.J.; Cho, C.W.; Yang, K.H. Development of tretinoin gels for enhanced transdermal delivery. Eur. J. Pharm. Biopharm., 2005, 60, 67-71.
30. Shin, S.C.; Kim, J.Y.; Oh, I.J. Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide. Drug Dev. Ind. Pharm., 2000, 26, 307-12.
31. Mohamed, M.I. Optimization of chlorphenesin emulgel formulation. AAPS Pharm. Sci. Tech., 2004, 6(3), Article 26.
32. Higuchi, W.I. Analysis of data on the medicament release from ointments. J. Pharm. Sci., 1962, 51, 802-04.
33. Guy, R.H.; Handgraft, J. The determination of drug release rates from topical dosage forms. Int. J. Pharm., 1990, 60, R1-R3.
34. Dias, M.; Farinha, A.; Faustino, E.; Hadgraft, J.; Pais, J.; Toscano, C. Topical delivery of caffeine from some commercial formulations. Int. J. Pharm., 1999, 182, 41-7.
35. Jug, M.; Kwokal, A.; Cetina-Čižmek, B. Influence of cyclodextrin complexation on piroxicam gel formulations. Acta Pharm., 2005, 55, 223-36.
36. Wu, P.C.; Obata, Y.; Fujikawa, M.; Li, C.J.; Higashiyama, K.; Takayama, K. Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer. J. Pharm. Sci., 2001, 90, 1004-014.
37. Femenía-Font, A.; Balaguer-Fernández, C.; Merino, V.; Rodilla, V.; López-Castellano, A. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur. J. Pharm. Biopharm., 2005, 61, 50-5.
38. Ferreira, S.H. Peripheral analgesic sites of action of antiinflammatory drugs. Int. J. Clin. Pract. Suppl., 2002, 128, 2-10.